Abstract:SARS-CoV-2 provokes devastating tissue damage by cytokine release syndrome and leads to multi-organ failure. Modeling the process of immune cell activation and subsequent tissue damage is a significant task. Organoids from human tissues advanced our understanding of SARS-CoV-2 infection mechanisms though, they are missing crucial components: immune cells and endothelial cells. This study aims to generate organoids with these components. We established vascular immune organoids from human pluripotent stem cells and examined the effect of SARS-CoV-2 infection. We demonstrated that infections activated inflammatory macrophages. Notably, the upregulation of interferon signaling supports macrophages’ role in cytokine release syndrome. We propose vascular immune organoids are a useful platform to model and discover factors that ameliorate SARS-CoV-2-mediated cytokine release syndrome.

What problem does this paper attempt to address?

This paper aims to solve the problem of how SARS - CoV - 2 infection activates inflammatory macrophages. Specifically, the researchers constructed human tissue - organoids containing vascular networks and immune cells (Vascular Immune Organoids, VIOs) to simulate the activation of immune cells and subsequent tissue damage during SARS - CoV - 2 infection. Through this method, they hope to better understand the cytokine release syndrome (Cytokine Release Syndrome, CRS) caused by SARS - CoV - 2 and the mechanism of multi - organ failure it causes, and explore possible treatment strategies to mitigate the fatal consequences of this infection. ### Research Background and Objectives - **Background**: The cytokine release syndrome (CRS) caused by SARS - CoV - 2 infection is one of the main causes of multi - organ failure in COVID - 19 patients. Although traditional tissue - organoids can simulate some infection mechanisms, they lack key immune cell and endothelial cell components, which limits their application in the study of CRS. - **Objectives**: Generate tissue - organoids (VIOs) containing vascular networks and immune cells to more comprehensively simulate the activation of immune cells and tissue damage during SARS - CoV - 2 infection, thereby providing an effective platform for the study of CRS. ### Main Findings - **Construction of VIOs**: The researchers differentiated endothelial progenitor cells and mesenchymal stem cells from human pluripotent stem cells and formed VIOs through specific culture conditions. - **SARS - CoV - 2 Infection**: After being exposed to SARS - CoV - 2, VIOs showed obvious cell death and apoptosis signals, indicating successful virus infection. - **Inflammatory Response**: In the infected VIOs, macrophages were significantly activated, as manifested by the up - regulation of the interferon signaling pathway and the increased expression of the pro - inflammatory cytokine IL - 6. These results support the important role of macrophages in CRS. ### Conclusions - **Effectiveness of VIOs**: VIOs can effectively simulate the activation of immune cells and tissue damage during SARS - CoV - 2 infection, providing a new tool for the study of CRS. - **Potential Applications**: VIOs are not only helpful for in - depth understanding of the pathological mechanisms of SARS - CoV - 2 infection, but can also be used to screen and evaluate potential therapeutic drugs to prevent or mitigate the fatal complications caused by SARS - CoV - 2 infection. Through this research, the authors hope that VIOs can become an important platform for studying SARS - CoV - 2 infection and the inflammatory response it triggers, thereby providing a scientific basis for the development of effective treatment strategies.

SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids

SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids

SARS-CoV-2 infection of endothelial cells, dependent on flow-induced ACE2 expression, drives hypercytokinemia in a vascularized microphysiological system

Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage

Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro

SARS-CoV-2 infection of human pluripotent stem cell-derived vascular cells reveals smooth muscle cells as key mediators of vascular pathology during infection

Modeling COVID-19 with Human Pluripotent Stem Cell-Derived Cells Reveals Synergistic Effects of Anti-inflammatory Macrophages with ACE2 Inhibition Against SARS-CoV-2.

An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts

Synergism of TNF- and IFN- Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung

Organoids: a New Research Model for SARS-CoV-2infection and Treatment

Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model

Modulations of Homeostatic ACE2, CD147, GRP78 Pathways Correlate with Vascular and Endothelial Performance Markers during Pulmonary SARS-CoV-2 Infection

SARS-CoV-2 N Protein Triggers Acute Lung Injury Via Modulating Macrophage Activation and Infiltration in in Vitro and in Vivo

Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids

SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation

Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Ductal Organoids